Putting an End to Cancer Health Disparities
Guest Post by Michael A. Caligiuri, MD Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the way. Despite this progress, cancer still has a disproportionate impact on disadvantaged and minority groups. In the U.S., black men face more than doubleRead More →